Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ) stock: key figures, P/E, revenue and dividend
Financials · United States
Rainier Acquisition Corporation Class A Ordinary Shares financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -3,800.00 USD | -6,221.00 USD |
| EBIT | -3,800.00 USD | -6,221.00 USD |
| Net income | -3,800.00 USD | -6,221.00 USD |
| Diluted EPS – continuing operations | -0.00 USD | -0.00 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Rainier Acquisition Corporation Class A Ordinary Shares
Rainier Acquisition Corporation focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Chardan Healthcare Acquisition 4 Company and changed its name to Rainier Acquisition Corporation in March 2026. The company was incorporated in 2023 and is based in New York, New York.
More stocks
- OptimumBank Holdings, Inc. (OPHC)
- UVAT Technology Co Ltd (3580.TWO)
- Yungjin Pharm Co Ltd (003520.KS)
- Devyser Diagnostics AB (DVYSR.ST)
- Hana Pharm Co Ltd (293480.KS)
- Kulmbacher Brauerei (KUL.MU)
- Elensys Co.,Ltd. (264850.KQ)
- Samyang Packaging (272550.KS)
- The Platinum Group Public Company Limited (PLAT.BK)
- Kee Tai Properties Co Ltd (2538.TW)
- Triple i Logistics Public Company Limited (III.BK)
- China Electric Manufacturing Corp (1611.TW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.